HRT Financial’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AMPH
VCM
BTW
HRT Financial's AMPH Position: Q1 2026 in Review
HRT Financial opened a new position in Amphastar Pharmaceuticals (AMPH) in Q1 2026: 56,181 shares worth $1.1M. The stake represents ﹤0.01% of the portfolio and ranks #1998 among its holdings. This is a return to the name: HRT Financial previously reported a position in AMPH as recently as Q3 2025.
HRT Financial first reported a position in AMPH in Q2 2020 and has held it in 13 quarters since. The position peaked at $2.5M in Q1 2025. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.
- HRT Financial held 56,181 shares of Amphastar Pharmaceuticals worth $1.1M as of Q1 2026.
- Amphastar Pharmaceuticals was a new HRT Financial position in Q1 2026.
- Amphastar Pharmaceuticals made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #1998 holding.
- HRT Financial first reported a position in Amphastar Pharmaceuticals in Q2 2020 and has held it in 13 quarters since.
- HRT Financial's Amphastar Pharmaceuticals position peaked at $2.5M in Q1 2025.
- 215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.
Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.